|Day Low/High||2,550.00 / 2,600.00|
|52 Wk Low/High||2,020.00 / 2,614.00|
Bayer-Monsanto stands a better chance than AT&T-Time Warner.
This is new doctrine having to do with innovation and the stifling of innovation to create new products.
The Swiss fertilizers maker says regulators in the EU and elsewhere have demanded more information.
M&A dollar volume is down as dealmakers worry about political uncertainties at home and abroad.
Regulatory issues will weigh on this deal, because of populist politics.
Forward-looking purchasing managers' indices and earnings from beleaguered lender Deutsche Bank feature among the other release highlights.
Jim Cramer ponders why M&A is just the start of the story and also wonders what a Democratic sweep would do to the markets.
For starters, trouble for banks, drugs, energy and M&A.
Here is why CBS, Constellation Brands, Monsanto and Aetna will be winners in 2017.
York Capital Management founder Jamie Dinan explained how investors should play the Monsanto (MON), Bayer (BAYRY) deal.
The middle market in M&A may seem like opportunity knocking for bulge bracket bankers, except someone's building a wall.
Bankers with the most deal volume in the third quarter varied across sectors, from regional banks to energy.
In highlights from this week's trading diary and posts, Kass tells us about how the outlook for the market is worsening and shares some pointers on low-priced stocks.
Insiders at these companies are scooping up shares of their own stock lately.
In highlights from this week's trading diary and posts, Kass tells us about how his near-term strategy and why Twitter will continue to fly solo.
Monsanto (MON) shares are likely to rise toward the top of their recent consolidation range. You can use stock options to profit from such a move.
A crude oil rally helps Wall Street rally on Wednesday to erase all losses endured a day earlier.
Stocks are higher on Wednesday as crude oil prices near the psychologically important $50 level.
Stocks climb on Wednesday as crude oil prices nears the psychologically-important $50 level.
Monsanto shares were in focus after reporting a profit of $0.07 a share, while analysts had expected a loss of $0.03.
Stock futures move higher on Wednesday morning after a read on the labor market shows 154,000 jobs added to private payrolls in the U.S. in September.
Monsanto (MON) reported an unexpected profit for the 2016 fourth quarter on Wednesday morning.
Monsanto Company (NYSE: MON) today announced fiscal year 2016 results, delivering above the company's most recent ongoing earnings per share guidance for the year.
U.S. stock futures point lower; Twitter is expected to field bids this week, says a report; Mike Pence and Tim Kaine square off in the vice presidential debate.
Earnings and labor market data take center stage on Wednesday, October 5.
There is downside risk when reviewing the longer-term technical picture of the weekly chart.
Monsanto (MON) is scheduled to report fiscal 2016 fourth quarter financial results before Wednesday's market open.
Monsanto Company (NYSE: MON) and Dow AgroSciences LLC, a wholly-owned subsidiary of The Dow Chemical Company (NYSE: DOW), announced today that the companies have reached a non-exclusive global option and licensing agreement...
For the week of October 3, the start of the fourth quarter, investors will get the September labor report and a slew of major earnings reports.
Wall Street will welcome the fourth quarter with a rush of new data, most notably the jobs report for September that will be released on Friday.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.